What Bruker’s DISQVER acquisition means for sepsis and bloodstream infection testing
Bruker acquires DISQVER from Noscendo, adding blood-based clinical metagenomics as it pursues diagnostic registration and wider adoption.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Why Bruker’s ESCMID 2026 microbiology expansion could matter for hospital labs and infection control
Bruker expanded its microbiology portfolio at ESCMID 2026. Read what the new MALDI and outbreak tools could mean for labs and infection control.